Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield<sup>TM</sup>) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Covishield<sup>TM</sup>) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021

We estimated the effectiveness of two doses of the ChAdOx1 nCoV-19 (Covishield) vaccine against any COVID-19 infection among individuals ≥45 years in Chennai, Tamil Nadu, India. A community-based cohort study was conducted from May to September 2021 in a selected geographic area in Chennai. The esti...

Full description

Bibliographic Details
Main Authors: Sharan Murali, Manikandanesan Sakthivel, Kamaraj Pattabi, Vettrichelvan Venkatasamy, Jeromie Wesley Vivian Thangaraj, Anita Shete, Alby John Varghese, Jaganathan Arjun, Chethrapilly Purushothaman Girish Kumar, Pragya D Yadav, Rima Sahay, Triparna Majumdar, Manisha Dudhmal, Azhagendran Sivalingam, Sudha Rani Dhanapal, Augustine Durai Samy, Vijayaprabha Radhakrishnan, Murali Mohan Muni Krishnaiah, Suresh Arunachalam, Punita Muni Krishna Gandhi, Elavarasu Govindasamy, Prabhakaran Chinnappan, Dhana Priya Vadhani Sekar, Prakash Marappan, Ezhil Pounraj, Parasuraman Ganeshkumar, Murugesan Jagadeesan, Manish Narnaware, Gagandeep Singh Bedi, Prabhdeep Kaur, Manoj Murhekar
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
COVID-19 vaccines
vaccine effectiveness
ChAdOx1 nCoV-19
Covishield
AZD 1222
SARS-CoV-2 inactivated vaccines
Online Access:https://www.mdpi.com/2076-393X/10/6/970

Internet

https://www.mdpi.com/2076-393X/10/6/970

Similar Items